Argenica Therapeutics Ltd (AU:AGN) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Argenica Therapeutics Limited has announced the cancellation of 410,959 options due to an agreement between the company and the holder. The options, set to expire on September 30, 2024, were cancelled on June 14, 2024. This marks a significant change in the company’s securities structure.
For further insights into AU:AGN stock, check out TipRanks’ Stock Analysis page.